Pacira Pharmaceuticals, Inc. Reports 2012 Financial Results

March 7, 2013 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) today announced consolidated 2012 financial results and provided updates on the commercial launch of EXPAREL®(bupivacaine liposome injectable suspension) for postsurgical pain in the United States.

Twitter
LinkedIn
Facebook
Email
Print

Earnings

Pacira Biosciences